Published in Gastroenterology on February 01, 1992
Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899]. BMC Gastroenterol (2003) 0.98
Portal venous flow pattern as a useful tool for predicting esophageal varix bleeding in cirrhotic patients. Dig Dis Sci (2005) 0.78
Clinical trial of prophylactic endoscopic variceal ligation for esophageal varices. J Gastroenterol (1997) 0.77
Per rectal portal scintigraphy as a useful tool for predicting esophageal variceal bleeding in cirrhotic patients. World J Gastroenterol (2007) 0.77
Liver disease. Postgrad Med J (1994) 0.76
Prophylactic sclerotherapy: meta-analysis versus 'aggregate' analysis. Gastroenterology (1992) 0.75
Long term management of oesophageal varices. Drugs (1992) 0.75
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Evaluation of the new API 20C strip for yeast identification against a conventional method. J Clin Microbiol (1979) 3.76
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia (2007) 2.96
Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem (1989) 2.57
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res (1998) 2.56
Patient literacy and the readability of smoking education literature. Am J Public Health (1989) 2.55
Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem (1993) 1.90
The influence of smoking on vitamin C status in adults. Am J Public Health (1989) 1.90
Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun (1990) 1.88
M6P/IGF2R imprinting evolution in mammals. Mol Cell (2000) 1.77
Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J Biol Chem (1989) 1.68
Glycoprotein synthesis in yeast. Identification of Man8GlcNAc2 as an essential intermediate in oligosaccharide processing. J Biol Chem (1982) 1.49
Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. J Clin Oncol (1998) 1.48
Systematic review of diagnostic tests for vaginal trichomoniasis. Infect Dis Obstet Gynecol (2000) 1.40
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells. Leukemia (2004) 1.38
Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology (1996) 1.32
Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest (1991) 1.32
Anticoagulant patient information material is written at high readability levels. Stroke (2000) 1.29
Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology (1998) 1.28
Improving patient comprehension of literature on smoking. Am J Public Health (1989) 1.27
Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia. Oncogene (2007) 1.27
Outpatient consultation: interaction between the general internist and the specialist. J Gen Intern Med (1987) 1.26
Molecular cloning of rat intestinal mucin. Lack of conservation between mammalian species. J Biol Chem (1991) 1.25
Effect of glucosylation of lipid intermediates on oligosaccharide transfer in solubilized microsomes from Saccharomyces cerevisiae. J Biol Chem (1980) 1.24
Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features. Leukemia (2012) 1.24
Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia. Leukemia (2009) 1.24
Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells. Leukemia (2003) 1.23
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism. Leukemia (2006) 1.22
Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res (1987) 1.21
Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleeding. Ann Intern Med (1994) 1.19
Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J Biol Chem (1987) 1.16
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia. Leukemia (2012) 1.11
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood (1997) 1.10
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse. Leukemia (2012) 1.09
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. Leukemia (2011) 1.07
The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells. Leukemia (2012) 1.05
Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death Differ (2011) 1.04
Campath-1H monoclonal antibody therapy. Curr Opin Oncol (2000) 1.01
Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res (1996) 1.01
Nursing home patients transferred by ambulance to a VA emergency department. J Am Geriatr Soc (1991) 1.01
Health literacy and numeracy. JAMA (1999) 1.01
Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells. Oncol Res (1992) 0.99
Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology (1994) 0.98
Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem (2000) 0.98
Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer (1996) 0.97
Differentiation of PC12 pheochromocytoma cells by sodium butyrate. Brain Res (1987) 0.96
A sialoglycoprotein complex linked to the microvillus cytoskeleton acts as a receptor for pilus (AF/R1) mediated adhesion of enteropathogenic Escherichia coli (RDEC-1) in rabbit small intestine. J Cell Biol (1991) 0.95
Ascorbic acid requirements for smokers: analysis of a population survey. Am J Clin Nutr (1991) 0.94
Rat intestinal nucleotide-sugar pyrophosphatase. Localization, partial purification, and substrate specificity. J Biol Chem (1985) 0.93
Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer (1997) 0.93
Update on the biology of chronic lymphocytic leukemia. Curr Opin Oncol (2000) 0.93
Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Cancer Res (1999) 0.92
Novel presentation of acute myelogenous leukemia as symptomatic galactorrhea. Ann Intern Med (2001) 0.90
An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor. Mol Endocrinol (1998) 0.90
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism. Ann Oncol (2010) 0.90
Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro. Int J Cancer (1992) 0.90
Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res (1993) 0.89
The impact of educational loan burden on housestaff career decisions. J Gen Intern Med (1993) 0.89
Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis. Clin Infect Dis (1998) 0.89
Two types of transglutaminase in the PC12 pheochromocytoma cell line. Stimulation by sodium butyrate. J Biol Chem (1987) 0.89
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia. J Immunother (2001) 0.89
CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome? J Clin Oncol (1999) 0.88
Expression of native and deglycosylated colon cancer mucin antigens in normal and malignant epithelial tissues. Lab Invest (1990) 0.88
Sulfated lewis X determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin. J Biol Chem (1997) 0.88
Mucin-like antigens in a human pancreatic cancer cell line identified by murine monoclonal antibodies SPan-1 and YPan-1. Cancer Res (1988) 0.87
Human herpesvirus 8 genome is not found in whole bone marrow core biopsy specimens of patients with plasma cell dyscrasias. Ann Hematol (2002) 0.87
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies. Blood (2000) 0.87
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma. Leukemia (2009) 0.87
Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. Gastroenterology (1999) 0.86
Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29. Cancer Res (1992) 0.86
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia. Leukemia (2005) 0.86
Granulomatous Pneumocystis carinii pneumonia in patients with low-grade lymphoid malignancies: a diagnostic dilemma. Clin Infect Dis (1996) 0.86
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461. Ann Hematol (2004) 0.85
The structure of human intestinal apomucins. Am Rev Respir Dis (1991) 0.84
Differential mucin gene expression in human pancreatic and colon cancer cells. Biochem J (1991) 0.84
Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int J Cancer (1998) 0.84
XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells. Leukemia (2012) 0.83
Anaphylactoid reactions to methotrexate. Cancer (1996) 0.83
Attitudes of faculty members, residents, students, and community physicians toward health promotion. J Med Educ (1987) 0.83
Coxsackievirus-associated pancreatitis mimicking metastatic carcinoma. South Med J (1996) 0.83
Hearing loss in former prisoners of war of the Japanese. J Am Geriatr Soc (1996) 0.83
ABH blood group antigen expression, synthesis, and degradation in human colonic adenocarcinoma cell lines. Cancer Res (1989) 0.82
Blood group antigen synthesis and degradation in normal and cancerous colonic tissues. Gastroenterology (1990) 0.81
Comparison of metabolically labeled mucins of LS174T human colon cancer cells in tissue culture and xenograft. Tumour Biol (1989) 0.81
Community hospital transfers to a VA Medical Center. JAMA (1989) 0.81
Interhospital transfers, the COBRA Law (1985), and the use of a public assistance health plan. South Med J (1993) 0.80
Structural characterization of intact, branched oligosaccharides by high performance liquid chromatography and liquid secondary ion mass spectrometry. Anal Biochem (1988) 0.80
Physician extenders for cost-effective management of hypercholesterolemia. J Gen Intern Med (1996) 0.80
Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment. Mod Pathol (1997) 0.80
Epinephrine synthesis in the PC12 pheochromocytoma cell line. Eur J Pharmacol (1986) 0.80
Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen. Dis Markers (1993) 0.79
Laryngeal carcinoma presenting as platypnea. Chest (1994) 0.79
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia. Bone Marrow Transplant (2005) 0.79
Biosynthesis of two distinct types of mucin in HM3 human colon cancer cells. Biochem J (1994) 0.79
Mitochondria control of cell death induced by anti-HLA-DR antibodies. Leukemia (2003) 0.79
Smoking cessation in practice. Prim Care (1989) 0.78
Isolation and partial characterization of the oligosaccharide moieties of rat preputial beta-glucuronidase. Biochim Biophys Acta (1981) 0.78
Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy. Int J Cancer (1993) 0.78